The Radiologist's Role in Improving DBT Access Equity
Radiologists may not order a DBT exam for African American patients, but they can participate in improving access to the screening.
African American women have significantly less access to digital breast tomosynthesis (DBT) that do their white counterparts, according a study published recently in the Journal of the American College of Radiology.
Even though DBT improves cancer detection and reduces recall rates, researchers from PennMedicine found that, based on their study population of more than 385,000 women, only 44 percent of African American women undergo DBT. Among Asian and white women, the rates of 63 percent and 61 percent, respectively.
This inequity in access presents a significant problem because African American women are more likely to be diagnosed with more aggressive forms of breast cancer at younger ages. Having easier, more consistent access to could greatly improve their outcomes.
Although radiologists and mammographers do not order DBT exams for these women, they do have a role to play in improve access and reducing the inequity, said Linda Blount, MPH, president and chief executive officer for Black Women’s Health Imperative, a non-profit organization dedicated to improving health and wellbeing for African American women and girls.
Newsletter
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Mammography Study: AI Facilitates Greater Accuracy and Longer Fixation Time on Suspicious Areas
July 8th 2025While noting no differences in sensitivity, specificity or reading time with adjunctive AI for mammography screening, the authors of a new study noted a 4 percent higher AUC and increased fixation time on lesion regions.
Can Contrast-Enhanced Mammography be a Viable Screening Alternative to Breast MRI?
June 17th 2025While the addition of contrast-enhanced mammography (CEM) to digital breast tomosynthesis (DBT) led to over a 13 percent increase in false positive cases, researchers also noted over double the cancer yield per 1,000 women in comparison to DBT alone.
Contrast-Enhanced Mammography and High-Concentration ICM Dosing: What a New Study Reveals
June 16th 2025New research showed a 96 to 97 percent sensitivity for contrast-enhanced mammography (CEM) with an increased iodine delivery rate facilitating robust contrast enhancement for women with aggressive breast cancer.
